meglumine has been researched along with Muscular Dystrophy, Duchenne in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alsaied, T; Khoury, PR; Lang, SM; Ryan, TD; Taylor, MD | 1 |
Ennis, DB; Halnon, N; Kim, GH; Maforo, NG; Magrath, P; Moulin, K; Prosper, A; Renella, P; Shao, J; Wu, HH | 1 |
BĂ©hin, A; Carlier, PG; Eymard, B; Gilles, R; Marty, B; Stojkovic, T; Toussaint, M; Wahbi, K | 1 |
Alsaied, T; Lang, SM; Moore, RA; Rattan, M; Ryan, TD; Taylor, MD | 1 |
4 other study(ies) available for meglumine and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Topics: Adipose Tissue; Adolescent; Cardiomyopathies; Child; Contrast Media; Disease Progression; Female; Fibrosis; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Muscular Dystrophy, Duchenne; Myocardium; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2021 |
T
Topics: Adolescent; Age Factors; California; Cardiomyopathies; Case-Control Studies; Child; Contrast Media; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Muscular Dystrophy, Duchenne; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2020 |
Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging.
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Case-Control Studies; Contrast Media; France; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Meglumine; Muscular Dystrophy, Duchenne; Organometallic Compounds | 2019 |
Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management.
Topics: Adolescent; Cardiomyopathies; Child; Contrast Media; Cost Savings; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Muscular Dystrophy, Duchenne; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Time Factors; Workflow | 2019 |